Megakaryocyte population in human bone marrow increases with estrogen treatment: A role in bone remodeling?

Bone

Volumn 27, Issue 3, 2000, Pages 397-401

  Bord, S ^a   Vedi, S ^a   Beavan, S R ^a   Horner, A ^a   Compston, J E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Estrogen; Estrogen receptors; HRT; Human bone; Megakaryocytes; TGF

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR III; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW; BONE REMODELING; CELL COUNT; CELL POPULATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POSTMENOPAUSE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TREATMENT OUTCOME;

ADULT; AGED; BONE MARROW CELLS; BONE REMODELING; CASE-CONTROL STUDIES; CELL COUNT; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTES; MENOPAUSE; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 0033827528     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00336-7     Document Type: Article

References (27)

1. Chow J., Tobias J.H., Colston K.W., Chambers T.J. Estrogen maintains trabecular volume in rats not only by suppression of resorption but also by stimulation of bone formation. J Clin Invest. 89:1992;74-78.
2. Christiansen C., Christensen M.S., McNair P.L., Hagen C., Stocklund K.E., Transbol I. Prevention of early menopausal bone loss conducted 2 year study in 315 normal females . Eur J Clin Invest. 10:1980;273-279.
3. Ellis M.H., Avraham H., Groopman J.E. The regulation of megakaryocytopoiesis. Blood Rev. 9:1995;1-6.
4. Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., Riggs B.L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 241:1988;84-86.
5. Genever P.G., Wilkinson D.J.P., Patton A.J., Peet N.M., Hong Y., Mathur A., Erusalimsky J.D., Skerry T. Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood. 93:1999;2876-2883.
6. House G.M., Kohlmeier L., Chattopadhyay N., Kifor O., Yamaguchi T., Leboff M.S., Glowacki J., Brown E.M. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res. 12:1997;1959-1970.
7. Hoyland J.A., Mee A.P., Baird P., Braidman I.P., Mawer E.B., Freemont A.J. Demonstration of estrogen receptor mRNA in bone using in situ reverse transcriptase polymerase chain reaction. Bone. 20:1997;87-92.
8. Huffman R., Straneva J., Yang H.H., Bruno E., Brandt J. New insights into the regulation of megakaryocytopoiesis. Blood Cells. 13:1987;75-86.
9. Kelm R.J., Hair G.A., Mann K.G., Grant B.W. Characterization of human osteoblast and megakaryocyte-derived osteonectin (SPARC). Blood. 80:1992;3112-3119.
10. Komm B.S., Terpening C.M., Benz D.J., Graeme K.A., Galegas A., Kore M., Greene G.L., O'Malley B.W., Hausler M.R. Estrogen binding receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science. 241:1988;81-83.
11. Lindsay R., Hart D.M., Forrest C., Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet. ii:1980;1151-1153.
12. Lufkin E.G., Wahner H.W., O'Fallon W.M., Hodgson S.F., Kotowicz M.A., Lane A.W., Judd H.L., Caplan R.H., Riggs B.L. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 117:1992;1-9.
13. Pacifici R., Brown C., Puseck E., Friedrich E., Slatopolsky E., Maggio D., McCracken R., Avoli L.V. Effects of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA. 88:1991;5134-5138.
14. Pensler J.M., Radosevich J.A., Higbee R., Langman C.B. Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res. 5:1990;797-802.
15. Thiede M.A., Smock S.L., Petersen D.N., Grasser W.A., Thompson D.D., Nishimoto S.K. Presence of messenger-ribonucleic-acid encoding osteocalcin, a marker of bone turnover, in bone megakaryocytes and peripheral blood platelets. Endocrinology. 135:1994;929-937.
16. Samuels A., Perry M.J., Tobias J.H. Analysis of the relationship between oestrogen-induced osteosclerosis and changes in megakaryocyte populations in female mice. J Bone Miner Res. 13:1998;16.
17. Samuels A., Perry M.J., Tobias J.H. High-dose estrogen induces de novo medullary bone formation in female mice. J Bone Miner Res. 14:1999;178-185.
18. Takai H., Kanematsu M., Yano K., Tsuda F., Higashio K., Ikeda K., Watanabe K., Yamada Y. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem. 273:1998;27091-27096.
19. Thiede M.A., Smock S.L., Mason-Savas A., Mackay C.A., Odgren P.R., Marks S.C. Thrombocytopenia in the toothless (osteopetrotic) rat and its rescue by treatment with colony-stimulating factor-1. Exp Hematol. 24:1996;722-727.
20. Thiede M.A., Smock S.L., Peterson D.N., Grasser W.A., Thompson D.D., Nishimoto S.K. The presence of messenger-ribonucleic-acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. J Endocrinol. 135:1994;929-937.
21. Tobias J.H., Chow J., Colston K.W., Chambers T.J. High-concentrations of 17-beta-estradiol stimulate trabecular bone formation in adult female rats. Endocrinology. 128:1991;408-412.
22. Vedi S., Purdie D.W., Ballard P., Bord S., Cooper A.C., Compston J.E. Bone remodelling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Osteoporos Int. 10:1999;52-58.
23. Vedi S., Croucher P.I., Garrahan N.J., Compston J.E. Effects of hormone replacement therapy on cancellous bone microstructure in postmenopausal women. Bone. 19:1996;69-72.
24. Wahab M., Ballard P., Purdie D.W., Cooper A., Wilson J.C. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy. Br J Obstet Gynaecol. 104:1997;728-731.
25. Wakikawa T., Shioi A., Hino M., Inaba M., Nishizawa Y., Tatsumi N., Hirotoshi M., Otani S. Thrombopoietin inhibits in vitro osteoclastogenesis from murine bone marrow cells. Endocrinology. 138:1997;4160-4166.
26. Yan X.Q., Lacey D., Hill D., Chen Y., Fletcher F., Hawley R.G., McNiece I.K. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl-ligand) reversal of disease by bone marrow transplantation . Blood. 88:1996;402-409.
27. Zheng M.H., Wood D.J., Papadimitriou J.M. What's new in the role of cytokines on osteoblast proliferation and differentiation. Path Res Pract. 188:1992;1104-1121.